210 related articles for article (PubMed ID: 23785290)
1. Sub-inhibitory concentrations of human α-defensin potentiate neutralizing antibodies against HIV-1 gp41 pre-hairpin intermediates in the presence of serum.
Demirkhanyan L; Marin M; Lu W; Melikyan GB
PLoS Pathog; 2013; 9(6):e1003431. PubMed ID: 23785290
[TBL] [Abstract][Full Text] [Related]
2. Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein.
Joshi VR; Newman RM; Pack ML; Power KA; Munro JB; Okawa K; Madani N; Sodroski JG; Schmidt AG; Allen TM
PLoS Pathog; 2020 May; 16(5):e1008577. PubMed ID: 32392227
[TBL] [Abstract][Full Text] [Related]
3. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.
Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699
[TBL] [Abstract][Full Text] [Related]
4. Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity.
Drummer HE; Hill MK; Maerz AL; Wood S; Ramsland PA; Mak J; Poumbourios P
PLoS Pathog; 2013; 9(4):e1003218. PubMed ID: 23592978
[TBL] [Abstract][Full Text] [Related]
5. Binding of HIV-1 gp41-directed neutralizing and non-neutralizing fragment antibody binding domain (Fab) and single chain variable fragment (ScFv) antibodies to the ectodomain of gp41 in the pre-hairpin and six-helix bundle conformations.
Louis JM; Aniana A; Lohith K; Sayer JM; Roche J; Bewley CA; Clore GM
PLoS One; 2014; 9(8):e104683. PubMed ID: 25105806
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.
Yi HA; Fochtman BC; Rizzo RC; Jacobs A
Curr HIV Res; 2016; 14(3):283-94. PubMed ID: 26957202
[TBL] [Abstract][Full Text] [Related]
7. Early steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation.
Miyauchi K; Kozlov MM; Melikyan GB
PLoS Pathog; 2009 Sep; 5(9):e1000585. PubMed ID: 19763181
[TBL] [Abstract][Full Text] [Related]
8. Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates.
Golding H; Zaitseva M; de Rosny E; King LR; Manischewitz J; Sidorov I; Gorny MK; Zolla-Pazner S; Dimitrov DS; Weiss CD
J Virol; 2002 Jul; 76(13):6780-90. PubMed ID: 12050391
[TBL] [Abstract][Full Text] [Related]
9. Antigenic properties of the human immunodeficiency virus transmembrane glycoprotein during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2002 Dec; 76(23):12123-34. PubMed ID: 12414953
[TBL] [Abstract][Full Text] [Related]
10. Membrane-transferring regions of gp41 as targets for HIV-1 fusion inhibition and viral neutralization.
Huarte N; Lorizate M; Pérez-Payá E; Nieva JL
Curr Top Med Chem; 2011 Dec; 11(24):2985-96. PubMed ID: 22044227
[TBL] [Abstract][Full Text] [Related]
11. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.
Nelson JD; Kinkead H; Brunel FM; Leaman D; Jensen R; Louis JM; Maruyama T; Bewley CA; Bowdish K; Clore GM; Dawson PE; Frederickson S; Mage RG; Richman DD; Burton DR; Zwick MB
Virology; 2008 Jul; 377(1):170-83. PubMed ID: 18499210
[TBL] [Abstract][Full Text] [Related]
12. The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
Montefiori DC; Filsinger Interrante MV; Bell BN; Rubio AA; Joyce JG; Shiver JW; LaBranche CC; Kim PS
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431684
[TBL] [Abstract][Full Text] [Related]
13. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
Alsahafi N; Debbeche O; Sodroski J; Finzi A
PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
[TBL] [Abstract][Full Text] [Related]
14. Neutralization resistance of virological synapse-mediated HIV-1 Infection is regulated by the gp41 cytoplasmic tail.
Durham ND; Yewdall AW; Chen P; Lee R; Zony C; Robinson JE; Chen BK
J Virol; 2012 Jul; 86(14):7484-95. PubMed ID: 22553332
[TBL] [Abstract][Full Text] [Related]
15. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
[TBL] [Abstract][Full Text] [Related]
16. Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies.
Caillat C; Guilligay D; Torralba J; Friedrich N; Nieva JL; Trkola A; Chipot CJ; Dehez FL; Weissenhorn W
Elife; 2021 Apr; 10():. PubMed ID: 33871352
[TBL] [Abstract][Full Text] [Related]
17. Designing a soluble near full-length HIV-1 gp41 trimer.
Gao G; Wieczorek L; Peachman KK; Polonis VR; Alving CR; Rao M; Rao VB
J Biol Chem; 2013 Jan; 288(1):234-46. PubMed ID: 23184960
[TBL] [Abstract][Full Text] [Related]
18. Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41.
Hrin R; Montgomery DL; Wang F; Condra JH; An Z; Strohl WR; Bianchi E; Pessi A; Joyce JG; Wang YJ
AIDS Res Hum Retroviruses; 2008 Dec; 24(12):1537-44. PubMed ID: 19102685
[TBL] [Abstract][Full Text] [Related]
19. Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil.
Champagne K; Shishido A; Root MJ
J Biol Chem; 2009 Feb; 284(6):3619-27. PubMed ID: 19073602
[TBL] [Abstract][Full Text] [Related]
20. Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensin.
Demirkhanyan LH; Marin M; Padilla-Parra S; Zhan C; Miyauchi K; Jean-Baptiste M; Novitskiy G; Lu W; Melikyan GB
J Biol Chem; 2012 Aug; 287(34):28821-38. PubMed ID: 22733823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
